Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 878672 00 5. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110467580A enables high-purity Lesinurad resolution using quinoline alkaloids, ensuring cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN107098866A reveals cost-effective chemical resolution for Lesinurad enantiomers ensuring high purity and supply chain stability for pharmaceutical manufacturing partners globally.
Patent CN107098866A offers cost-effective chiral resolution for Lesinurad intermediates, ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Novel Lesinurad synthesis patent CN106866560A offers high yield and purity. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.